Analysis of ligand-receptor pairs revealed interactions between CXCR1+ neutrophils and tumor cells involving TGFA-EGFR and EGF-EGFR, potentially explaining aspects of resistance to third-generation EGFR-TKIs due to sustained EGFR activation (Fig. 4f). The gene discussed is EGFR; the disease is neoplasm.